1-9. (canceled)
10. A vector comprising a nucleic acid encoding a recombinant CD40L polypeptide consisting of amino acid residues 21-261 of SEQ ID NO:2, wherein said vector is pARGCD40L.
11-24. (canceled)
25. A dendritic cell which preferentially induces a population of CD28+ CD45RA\u2212 memoryeffector T cells from a population of antigen-specific T cells.
26. A vaccine comprising the dendritic cell of claim 25.
27. A method for preparing mature dendritic cells (DCs), comprising the sequential steps of:
(a) signaling isolated immature dendritic cells (iDCs) with a first signal comprising an interferon gamma receptor (IFN-\u03b3R) agonist and a TNF-\u03b1R agonist to produce IFN-\u03b3R agonist signaled dendritic cells; and
(b) signaling said IFN-\u03b3R agonist signaled dendritic cells with a second transient signal comprising an effective amount of a CD40L polypeptide to produce CCR7+ mature dendritic cells; wherein the CD40L polypeptide consists essentially of amino acid residues 21-261 of SEQ ID NO:2 or is a polypeptide having at least 80% sequence identity to amino acid residues 21-261 of SEQ ID NO:2.
28. The method of claim 27, wherein the CD40L protein is encoded by an RNA corresponding to the cDNA of SEQ ID NO:30 or SEQ ID NO:33, or a variant which differs due to codon degeneracy, wherein said RNA is optionally capped andor polyadenylated.
29. The method of claim 27, wherein the dendritic cell is transfected with an mRNA encoding the CD40L polypeptide.
30. The method of claim 27, wherein the dendritic cell is mature at the time of transfection.
31. The method of claim 27, further comprising contacting said iDCs andor said signaled DCs with PGE2.
32. The method of claim 27, wherein steps (a) and (b) further comprise contacting said cells with GM-CSF and at least one of IL-4 or IL-13.
33. The method of claim 27, wherein the cells in step (a) are contacted with TNF-\u03b1.
34. The method of claim 33, further comprising contacting the cells in step (a) with PGE2.
35. The method of claim 27, wherein the IFN-\u03b3R agonist is IFN-\u03b3.
36. The method of claim 27, wherein the first signal comprises IFN-\u03b3, TNF-\u03b1 and PGE2.
37. The method of claim 27, wherein the first signal comprises IFN-\u03b3, TNF-\u03b1 and PGE2 and step (b) comprises transfecting said dendritic cells with an RNA encoding said CD40L polypeptide.
38. The method of claim 27, further comprising contacting the immature dendritic cells andor IFN-\u03b3R agonist signaled dendritic cells andor CCR7+ mature dendritic cells with a compound selected from the group consisting of: galactosylceramides, glycosylceramides, galactofuranosylceramides, arabinopyranosylceramides, \u03b1-C-galactosylceramides and \u03b1-S-galactosylceramides.
39. The method of claim 38, wherein the compound is a galactosylceramide.
40. The method of claim 39, wherein the galactosylceramide is (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino)-1,3,4-octadecanetriol (KRN7000).
41. The method of claim 27, wherein the CD40L polypeptide consists of amino acid residues 21-261 of SEQ ID NO:2.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A delivering tap, for a \u201cbag in box\u201d type liquid vessel, the delivering tap comprising:
a) a substantially-cylindrical elongated body equipped with an end comprising rings adapted to perform a seal on a mouth with which the vessel bag is equipped, and with an opposite end comprising cam means, the elongated body further comprising a planar member placed in a plane which is perpendicular to an axis of the body; and
b) a plug comprising a cylindrical end and an operating knob equipped with engaging means of the cam means, the plug being adapted to be operatively connected to the end of the body in order to assume, when driving the cam means, an opening position in which liquid contained in the vessel is delivered and a closing position of the vessel;
where the plug is made in a single piece;
where the plug is equipped with tamper-preventing warranty sealing means adapted to signal a possible tampering when opening the tap; and
where the body is equipped with housing means adapted to contain the tamper-preventing warranty sealing means.
2. A delivering tap according to claim 1, where the tamper-preventing warranty sealing means comprises at least one ring that surrounds the cylindrical end and that is connected to the knob through a plurality of connecting members, the connecting members being adapted to be detached from the knob or the ring or both the knob and the ring upon first rotating the plug when opening.
3. A delivering tap according to claim 2, where the housing means of the tamper-preventing-warranty sealing means comprises one or more than one groove adapted to immovably house the ring.
4. A delivering tap according to claim 1, where the cam comprises two walls, the walls being projecting outside a surface of the end of the body and being spirally wound around the end of the body.
5. A delivering tap according to claim 1, where the body and the cylindrical end of the plug are in mutual contact in two or more than two sealing points, in each one of the sealing points the surface of the body in contact with the cylindrical end being plane and the surface of the cylindrical end in contact with the body being spherical.
6. A process for manufacturing a delivering tap according to claim 1, the process comprising the steps of:
a) injection-molding the body;
b) molding the plug by providing an injection mold comprising two half-molds separated by a separation surface, the two half-molds comprising a fixed half-mold having inserted an injector or injecting bush, and comprising a movable half-mold and having inserted an expulsion device c) placing the plug to be molded next to the separation surface between the half-molds;
d) closing the injection mold;
e) injecting material for making the plug into the mold;
f) beginning to open the mold next to a separating area of the half-molds;
g) removing the movable half-mold;
h) simultaneously with the step of removing the movable half-mold, dragging saddles outwards, the saddles connected through slanted pegs to the movable half-mold, the saddles being used for making the sealing means, thereby freeing the sealing means;
i) simultaneously with dragging the saddles, freeing the front part of the plug;
where the fixed half-mold is connected to a female member in which two insert members are inserted, the insert members being integral with the female member and remaining inserted in the female member and unmoving on the fixed mold side, the insert members functioning to create, during coupling with an external male part being present on the movable half-mold, internal teeth of the knob of the plug and to tear away an end part of the injection spot;
j) simultaneously, dragging, through the movable half-mold and by means of a connecting member between the two half-molds, an intermediate male part being present on the fixed mold part, by means of a mold plate, thereby realizing a first forward advancement of the plug;
k) continuing to open the mold, thereby actuating a hydraulic extractor connected to a rear mold area in order to operate on mold members adapted to completely free the plug from the inserts being present on the fixed half-mold; and
l) completing the mold closure through the hydraulic extractor which, being anchored to the rear mold part through a threaded bar, drags in an opposite movement various plates and small tables completing the closure.